Chiriboga, Claudia A. http://orcid.org/0000-0001-6088-4889
Article History
Accepted: 17 July 2022
First Online: 27 August 2022
Declarations
:
: No funding was provided for the writing of this manuscript.
: Dr. Chiriboga receives grant funding from Avexis/Novartis, Biogen and Roche. She serves/served as consultant for Roche, Genentech, Avexis/Novartis and PTC and has served as Speaker in unlabeled educational talks for Biogen, Roche and Genentech.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Dr. Chiriboga was the sole author of this article.